Percutaneous coronary intervention versus coronary artery bypass graft surgery in dialysis‐dependent patients: A pooled meta‐analysis of reconstructed time‐to‐event data. Issue 10 (28th July 2022)

• Record Type: Journal Article
• Authors: Tasoudis, Panagiotis T.; Varvoglis, Dimitrios N.; Tzoumas, Andreas; Doulamis, Ilias P.; Tzani, Aspasia; Sá, Michel Pompeu; Kampaktsis, Polydoros N.; Gallo, Michele
• Is Part Of: Journal of cardiac surgery. Volume 37:Issue 10(2022)
• Page Start: 3365
• Page End: 3373
• Publication Date: 2022-07-28
• Subjects: cardiac surgical procedures -- cardiovascular surgical procedures -- coronary artery bypass -- myocardial revascularization -- percutaneous coronary intervention; Heart -- Surgery -- Periodicals; 617.412005
• DOI: 10.1111/jocs.16805
• Languages: English
• ISSNs: 0886-0440

Abstract

Abstract: Objective: Το perform a systematic review with meta‐analysis of published data comparing outcomes between a percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in dialysis‐dependent patients. Methods: We searched PubMed, Scopus, and Cochrane databases for studies including dialysis‐dependent patients who underwent either CABG or PCI. This meta‐analysis follows the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses statement. We conducted one‐stage and two‐stage meta‐analysis with Kaplan–Meier‐derived individual patient data for overall survival and meta‐analysis with the random‐effects model for the in‐hospital mortality and repeat revascularization. Results: Twelve studies met our eligibility criteria, including 13, 651 and 28, 493 patients were identified in the CABG and PCI arms, respectively. Patients who underwent CABG had overall improved survival compared with those who underwent PCI at the one‐stage meta‐analysis (hazard ratio [HR]: 1.12, 95% confidence interval [CI]: 1.09–1.16, p < .0001) and the two‐stage meta‐analysis (HR: 1.15, 95% CI: 1.08–1.23, p < .001, I 2 = 30.0%). Landmark analysis suggested that PCI offers better survival before the 8.5 months of follow‐up (HR: 0.96, 95% CI: 0.92–0.99, p = .043), while CABG offers an advantage after this timepoint (HR: 1.3, 95% CI: 1.22–1.32, p < .001). CABG was associated with increased odds for in‐hospital mortality (odds ratio [OR]: 1.70, 95% CI: 1.50–1.92, p < .001, I 2 = 0.0%) and decreased odds for repeat revascularization (OR: 0.22, 95% CI: 0.14–0.34, p < .001, I 2 = 58.08%). Conclusions: In dialysis‐dependent patients, CABG was associated with long‐term survival but a higher risk for early mortality. The risk for repeat revascularization was higher with PCI.